Some pharmacodynamic aspects on long-acting β-adrenoceptor agonists

General Pharmacology

Volumn 27, Issue 4, 1996, Pages 575-580

  Waldeck, Bertil ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

Airways; Formoterol; Salmeterol; Stereoisomers

Indexed keywords

ALPHA [[[3 (1 BENZIMIDAZOLYL) 1,1 DIMETHYLPROPYL]AMINO]METHYL] 2 FLUORO 4 HYDROXYBENZYL ALCOHOL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARMOTEROL; FORMOTEROL; LONG ACTING DRUG; PICUMETEROL; RP 58802B; SALMETEROL; UNCLASSIFIED DRUG;

ARTICLE; BRONCHODILATATION; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; HUMAN; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; STEREOCHEMISTRY;

EID: 0030176191     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(95)02052-7     Document Type: Review

References (54)

1. 2-adrenoceptor agonist bronchodilator. Life Sci. 52, 2145-2160.
2. Anderson G. A., Jäkel K., Mutz M. and John E. (1994a) Direct biophysical measurements support the diffusion microkinetic model of long acting beta-adrenoceptor agonist action. Am. J. Resp. Crit. Care Med. 149(4), A481.
3. Anderson G. P., Lindén A. and Rabe K. F. (1994b) Why are long-acting beta-adrenoceptor agonists long-acting? Eur. Respir. J. 7, 569-578.
4. 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. Br. J. Pharmac. 104, 665-671.
5. Bergendal A., Lindén A., Skoogh B.-E., Gerspacher M., Anderson G. P. and Lofdahl C.-G. (1996) Salmeterol-mediated reassertion of relaxation persists in guinea-pig trachea pretreated with aliphatic side chain structural analogues. Br. J. Pharmac. (in press).
6. 2-adrenoceptor agonist. Br. J. Pharmac. 92, 590P.
7. Brittain R. T., Dean C. M. and Jack D. (1976) Sympathomimetic bronchodilator drugs. Pharmac. Ther. B. 2, 423-462.
8. Bullowa J. G. M. and Kaplan D. M. (1903) On the hypodermatic use of adrenalin chloride in the treatment of asthmatic attacks. Medical News 83, 787-790.
9. Coleman R. A., Nials A. T., Johnson M. and Vardey C. J. (1994) Salmeterol: relationship between duration of action and lipophilicity? Am. J. Resp. Crit. Care Med. 149(4), A481.
10. 2-adrenoceptor agonist salmeterol in guinea-pig trachea. Br. J. Pharmac. 104, 1057-1061.
11. Erjefält I. and Persson C. G. A. (1991) Long duration and high potency of antiexudative effects of formoterol in guinea-pig tracheobronchial airways. Am. Rev. Respir. Dis. 144, 788-791.
12. Fügner A. (1989) Formation of oedema and accumulation of eosinophils in the guinea-pig lung. Int. Arch. Allergy Appl. Immunol. 88, 225-227.
13. 2-selective adrenoceptor agonist, SOM 1122. Clin. Exp. Pharmacol. Physiol. Suppl. 10, 51.
14. Ida H. (1976) Cardiorespiratory activities of 3-formylamino-4-hydroxy-α-(N-1-methyl-2-p-methoxyphenethylaminomet hyl)-benzylalcoholhemi-fumarate (BD40A) and some other β-adrenoceptor stimulants in conscious guinea pigs. Arzneim.-Forsch. 26, 1337-1340.
15. Jacobson K. A., Marr-Leisy D., Rosenkranz R. P., Verlander M.S., Melmon K. L. and Goodman M. (1983) Conjugates of catecholamines. I. N-Alkyl-functionalized carboxylic acid congeners and amides related to isoproterenol. J. Med. Chem. 26, 492-499.
16. Jeppsson A.-B., Löfdahl G., Waldeck B. and Widmark E. (1989a) On the predictive value of experiments in vitro in the evaluation of the effect duration of bronchodilator drugs for local administration. Pulmonary Pharmacology 2, 81-85.
17. Jeppsson A.-B., Roos C., Waldeck B. and Widmark E. (1989b) Pharmacodynamic and pharmacokinetic aspects on the transport of bronchodilator drugs through the tracheal epithelium of the guinea-pig. Pharmacol. Toxicol. 64, 58-63.
18. Jeppsson A.-B., Källström B.-L. and Waldeck B. (1992) Studies on the interaction between formoterol and salmeterol in guinea-pig trachea in vitro. Pharmacol. Toxicol. 71, 272-277.
19. Jeppsson A.-B., Nilsson E. and Waldeck B. (1994) Formoterol and salmeterol are both long acting compared to terbutaline in the isolated perfused and ventilated guinea-pig lung. Eur. J. Pharmac. 257, 137-143.
20. Johnson M., Butchers P. R., Coleman R. A., Nials A. T., Strong P., Sumner M. J., Vardey C. J. and Whelan C. J. (1993) The pharmacology of salmeterol. Life Sci. 52, 2131-2143.
21. 2-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro. Br. J. Pharmac. 113, 687-692.
22. 2-selectivity of TA-2005, a newly developed bronchodilating agent, in isolated guinea-pig tissues. Japan J. Pharmac. 57, 175-185.
23. 2-agonists. Biol. Pharm. Bull. 17, 1047-1052.
24. Lemoine H. and Overlack C. (1992) Highly potent beta-2 sympathomimetics convert to less potent partial agonists as relaxants of guinea-pig tracheae maximally contracted by carbachol: comparison of relaxation with receptor binding and adenylate cyclase stimulation. J. Pharmac. Exp. Ther. 261, 258-270.
25. Lindén A., Bergendal A., Ullman A., Skoogh B.-E. and Löfdahl C.-G. (1991) High concentration of formoterol and salmeterol in the isolated guinea-pig trachea: reassertion of smooth muscle relaxation after beta blockade followed by wash-out. Am. Rev. Respir. Dis. 143, 4(2), A749.
26. Lindén A., Bergendal A., Ullman A., Skoogh B.-E. and Löfdahl C.-G. (1993) Salmeterol, formoterol, and salbutamol in the isolated guinea-pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism. Thorax 48, 547-553.
27. 2-adrenoceptor agonist - D2343 - with long duration. Inhalation comparison with terbutaline in asthmatic patients. Allergy 39, 485-489.
28. 2-adrenoceptor agonist, compared to salbutamol in asthmatic patients. Acta Pharmacol. Toxicol. Suppl. 5(2), 229.
29. 2-adrenoceptor agonist. Allergy 44, 264-271.
30. Munoz N. M., Rabe K. F., Vita A. J., McAllister K., Mayer D., Weiss M. and Leff A. R. (1995) Paradoxical blockade of beta adrenergically mediated inhibition of stimulated eosinophil secretion by salmeterol. J. Pharmac. Exp. Ther. 273, 850-854.
31. Murase K., Mase T., Ida H. Takahashi K. and Murakami M. (1977) New β-adrenoceptor stimulants. Studies on 3-acylamino-4-hydroxy-α-(N-substituted aminomethyl)benzyl alcohol. Chem. Pharm. Bull. 25, 1368-1377.
32. Naline E., Zhangy Y., Qian Y., Mairon N., Anderson G. P., Grandordy B. and Advenier C. (1994) Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus. Eur. J. Pharmac. 7, 914-920.
33. Nials A. T., Coleman R. A., Johnson M., Magnussen H., Rabe K. F. and Vardey C. J. (1993a) Effects of β-adrenoceptor agonists in human bronchial smooth muscle. Br. J. Pharmac. 110, 1112-1116.
34. 2-adrenoceptor agonist. Eur. Resp. J. 6, Suppl. 17, P1882.
35. 2-adrenoceptor agonist salmeterol. Br. J. Pharmac. 108, 507-515.
36. Nials A. T., Ball D. I., Butchers P. R., Coleman R. A., Humbles A. A., Johnson M. and Vardey C. J. (1994a) Formoterol on airway smooth muscle and human lung mast cells: a comparison with salbutamol and salmeterol. Eur. J. Pharmac. 251, 127-135.
37. 2-adrenoceptor agonist bronchodilators. Am. J. Resp. Crit. Care Med. 149(4), A481.
38. Nials A. T., Coleman R. A., Johnson M. and Vardey C. J. (1994c) The β-adrenoceptor pharmacology of the enantiomers of salmeterol. Am. J. Resp. Crit. Care Med. 149(4), A481.
39. O'Donnell J. M. (1988) Psychopharmacological consequences of activation of beta adrenergic receptors by SOM-1122. J. Pharmac. Exp. Ther. 246, 38-46.
40. Olsson O. A. T. and Svensson L.-Å. (1984) New lipophilic terbutaline ester prodrugs with long effect duration. Pharm. Res. 1, 19-23.
41. Rabe K. F., Giembycz M. A., Dent G., Perkins R. S., Evans P. and Barnes P. J. (1993a) Salmeterol is a competitive antagonist at β-adrenoceptors mediating inhibition of respiratory burst in guinea-pig eosinophils. Eur. J. Pharmac. 231, 305-308.
42. Rabe K. F., Jörres R., Nowak D., Behr N. and Magnussen H. (1993b) Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma. Am. Rev. Respir. Dis. 147, 1436-1441.
43. Rosenkranz R. P., Jacobson K. A., Verlander M. S., Klevans L., O'Donnell M., Goodman M. and Melmon K. L. (1986) Conjugates of catecholamines. IV. In vitro and in vivo pharmacological activity of monodisperse oligopeptide conjugates. J. Pharmac. Exp. Ther. 227, 267-273.
44. Smyth E. T., Pavord I. D., Wong C. S., Wisniewski A. F. Z., Williams J. and Tattersfield A. E. (1993) Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. Br. Med. J. 306, 543-545.
45. Standifer K. M., Pitha J. and Baker S. P. (1989) Carbostyril-based beta-adrenergic agonists: evidence for long lasting or apparent irreversible receptor binding and activation of adenylate cyclase activity in vitro. Naunyn Schmiedeberg's Arch. Pharmacol. 339, 129-137.
46. Svensson L-Å. (1987) Bambuterol - a prodrug-prodrug with built-in hydrolysis brake. Acta Pharm. Suec. 24, 333-341.
47. Trofast, J., Österberg K. Källström B.-L. and Waldeck B. (1991) Steric aspects of agonism and antagonism at β-adrenoceptors: synthesis of and pharmacological experiments with the enantiomers of formoterol and their diastereomers. Chirality 3, 443-450.
48. 2-agonist: comparison with salbutamol in adult asthmatic patients. Thorax 43, 674-678.
49. Ullman A., Bergendahl A., Lindén A., Waldeck B., Skoogh B.-E. and Löfdahl C.-G. (1992) Onset of action and duration of effect of formoterol and salmeterol compared to salbutamol in isolated guinea-pig trachea with or without epithelium. Allergy 47, 384-387.
50. 2-adrenoceptor agonist: assessment of antiasthma activity in the guinea-pig in vivo. Pulmonary Pharmacology 5, 203-212.
51. 2-adrenoceptor agonists in asthma: molecular pharmacological aspects. Thesis, Vrije Univeriteit, Amsterdam.
52. 2-adrenoceptor agonist, TA-2005. Eur. J. Pharmac. 227, 403-409.
53. Waldeck B., Jeppsson A.-B. and Widmark E. (1986) Partial agonism and functional selectivity: a study on β-adrenoceptor mediated effects in tracheal, cardiac and skeletal muscle. Acta Pharmacol. Et Toxicol. 58, 209-218.
54. Waldeck B. (1993) Biological significance of the enantiomeric purity of drugs. Chirality 5, 350-355.